nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—TEK—artery—uterine fibroid	0.013	0.025	CbGeAlD
Ponatinib—SRC—artery—uterine fibroid	0.0116	0.0222	CbGeAlD
Ponatinib—KDR—artery—uterine fibroid	0.0106	0.0205	CbGeAlD
Ponatinib—BCR—nipple—uterine fibroid	0.0101	0.0194	CbGeAlD
Ponatinib—BCR—myometrium—uterine fibroid	0.00867	0.0167	CbGeAlD
Ponatinib—FGFR4—female reproductive system—uterine fibroid	0.00857	0.0165	CbGeAlD
Ponatinib—LCK—nipple—uterine fibroid	0.00805	0.0155	CbGeAlD
Ponatinib—FGFR3—uterine cervix—uterine fibroid	0.0078	0.015	CbGeAlD
Ponatinib—FGFR4—female gonad—uterine fibroid	0.0078	0.015	CbGeAlD
Ponatinib—FGFR1—myometrium—uterine fibroid	0.00772	0.0148	CbGeAlD
Ponatinib—FGFR3—urethra—uterine fibroid	0.00717	0.0138	CbGeAlD
Ponatinib—FGFR3—mammalian vulva—uterine fibroid	0.00683	0.0131	CbGeAlD
Ponatinib—BCR—uterine cervix—uterine fibroid	0.00675	0.013	CbGeAlD
Ponatinib—BCR—decidua—uterine fibroid	0.00643	0.0124	CbGeAlD
Ponatinib—BCR—urethra—uterine fibroid	0.0062	0.0119	CbGeAlD
Ponatinib—BCR—endometrium—uterine fibroid	0.00611	0.0117	CbGeAlD
Ponatinib—FGFR1—uterine cervix—uterine fibroid	0.00601	0.0115	CbGeAlD
Ponatinib—KDR—nipple—uterine fibroid	0.00599	0.0115	CbGeAlD
Ponatinib—BCR—mammalian vulva—uterine fibroid	0.00591	0.0114	CbGeAlD
Ponatinib—FGFR3—female reproductive system—uterine fibroid	0.00585	0.0112	CbGeAlD
Ponatinib—FGFR1—decidua—uterine fibroid	0.00572	0.011	CbGeAlD
Ponatinib—BCR—cardiac atrium—uterine fibroid	0.00566	0.0109	CbGeAlD
Ponatinib—BCR—uterus—uterine fibroid	0.00563	0.0108	CbGeAlD
Ponatinib—FGFR1—urethra—uterine fibroid	0.00552	0.0106	CbGeAlD
Ponatinib—LCK—uterine cervix—uterine fibroid	0.00537	0.0103	CbGeAlD
Ponatinib—KIT—nipple—uterine fibroid	0.00531	0.0102	CbGeAlD
Ponatinib—FGFR1—mammalian vulva—uterine fibroid	0.00525	0.0101	CbGeAlD
Ponatinib—KDR—myometrium—uterine fibroid	0.00514	0.00989	CbGeAlD
Ponatinib—RET—decidua—uterine fibroid	0.00512	0.00985	CbGeAlD
Ponatinib—LCK—decidua—uterine fibroid	0.00512	0.00985	CbGeAlD
Ponatinib—FGFR2—uterine cervix—uterine fibroid	0.00511	0.00982	CbGeAlD
Ponatinib—BCR—female reproductive system—uterine fibroid	0.00506	0.00972	CbGeAlD
Ponatinib—FGFR1—cardiac atrium—uterine fibroid	0.00503	0.00967	CbGeAlD
Ponatinib—FLT3—female reproductive system—uterine fibroid	0.00502	0.00966	CbGeAlD
Ponatinib—FGFR1—uterus—uterine fibroid	0.00501	0.00962	CbGeAlD
Ponatinib—FGFR2—smooth muscle tissue—uterine fibroid	0.00496	0.00954	CbGeAlD
Ponatinib—LCK—urethra—uterine fibroid	0.00494	0.0095	CbGeAlD
Ponatinib—TEK—smooth muscle tissue—uterine fibroid	0.00476	0.00915	CbGeAlD
Ponatinib—LCK—mammalian vulva—uterine fibroid	0.0047	0.00904	CbGeAlD
Ponatinib—TEK—decidua—uterine fibroid	0.00466	0.00897	CbGeAlD
Ponatinib—ABL1—nipple—uterine fibroid	0.00462	0.00889	CbGeAlD
Ponatinib—BCR—female gonad—uterine fibroid	0.0046	0.00885	CbGeAlD
Ponatinib—BCR—vagina—uterine fibroid	0.00457	0.00879	CbGeAlD
Ponatinib—FLT3—female gonad—uterine fibroid	0.00457	0.00879	CbGeAlD
Ponatinib—KIT—myometrium—uterine fibroid	0.00456	0.00876	CbGeAlD
Ponatinib—TEK—urethra—uterine fibroid	0.0045	0.00865	CbGeAlD
Ponatinib—LCK—uterus—uterine fibroid	0.00448	0.00861	CbGeAlD
Ponatinib—TEK—endometrium—uterine fibroid	0.00443	0.00851	CbGeAlD
Ponatinib—SRC—uterine cervix—uterine fibroid	0.00435	0.00836	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—uterine fibroid	0.00431	0.00829	CbGeAlD
Ponatinib—FGFR2—uterus—uterine fibroid	0.00426	0.00818	CbGeAlD
Ponatinib—SRC—smooth muscle tissue—uterine fibroid	0.00423	0.00813	CbGeAlD
Ponatinib—PDGFRA—decidua—uterine fibroid	0.00423	0.00813	CbGeAlD
Ponatinib—SRC—decidua—uterine fibroid	0.00414	0.00797	CbGeAlD
Ponatinib—TEK—cardiac atrium—uterine fibroid	0.0041	0.00789	CbGeAlD
Ponatinib—FGFR1—female gonad—uterine fibroid	0.00409	0.00787	CbGeAlD
Ponatinib—TEK—uterus—uterine fibroid	0.00408	0.00785	CbGeAlD
Ponatinib—FGFR1—vagina—uterine fibroid	0.00407	0.00782	CbGeAlD
Ponatinib—KDR—uterine cervix—uterine fibroid	0.004	0.00769	CbGeAlD
Ponatinib—ABL1—myometrium—uterine fibroid	0.00397	0.00763	CbGeAlD
Ponatinib—KDR—smooth muscle tissue—uterine fibroid	0.00389	0.00748	CbGeAlD
Ponatinib—FGFR2—female reproductive system—uterine fibroid	0.00383	0.00736	CbGeAlD
Ponatinib—KDR—decidua—uterine fibroid	0.00381	0.00733	CbGeAlD
Ponatinib—PDGFRA—uterus—uterine fibroid	0.0037	0.00711	CbGeAlD
Ponatinib—KDR—urethra—uterine fibroid	0.00368	0.00707	CbGeAlD
Ponatinib—TEK—female reproductive system—uterine fibroid	0.00367	0.00705	CbGeAlD
Ponatinib—LCK—female gonad—uterine fibroid	0.00366	0.00705	CbGeAlD
Ponatinib—SRC—cardiac atrium—uterine fibroid	0.00364	0.00701	CbGeAlD
Ponatinib—LCK—vagina—uterine fibroid	0.00364	0.007	CbGeAlD
Ponatinib—KDR—endometrium—uterine fibroid	0.00362	0.00696	CbGeAlD
Ponatinib—KIT—uterine cervix—uterine fibroid	0.00355	0.00682	CbGeAlD
Ponatinib—KDR—mammalian vulva—uterine fibroid	0.0035	0.00673	CbGeAlD
Ponatinib—FGFR2—female gonad—uterine fibroid	0.00348	0.00669	CbGeAlD
Ponatinib—KIT—smooth muscle tissue—uterine fibroid	0.00345	0.00663	CbGeAlD
Ponatinib—KIT—decidua—uterine fibroid	0.00338	0.0065	CbGeAlD
Ponatinib—KDR—cardiac atrium—uterine fibroid	0.00335	0.00645	CbGeAlD
Ponatinib—TEK—female gonad—uterine fibroid	0.00334	0.00642	CbGeAlD
Ponatinib—KDR—uterus—uterine fibroid	0.00334	0.00641	CbGeAlD
Ponatinib—PDGFRA—female reproductive system—uterine fibroid	0.00332	0.00639	CbGeAlD
Ponatinib—SRC—female reproductive system—uterine fibroid	0.00326	0.00627	CbGeAlD
Ponatinib—KIT—urethra—uterine fibroid	0.00326	0.00627	CbGeAlD
Ponatinib—KIT—endometrium—uterine fibroid	0.00321	0.00617	CbGeAlD
Ponatinib—KIT—mammalian vulva—uterine fibroid	0.0031	0.00596	CbGeAlD
Ponatinib—ABL1—uterine cervix—uterine fibroid	0.00309	0.00594	CbGeAlD
Ponatinib—PDGFRA—female gonad—uterine fibroid	0.00302	0.00581	CbGeAlD
Ponatinib—PDGFRA—vagina—uterine fibroid	0.00301	0.00578	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—uterine fibroid	0.003	0.00577	CbGeAlD
Ponatinib—KDR—female reproductive system—uterine fibroid	0.003	0.00576	CbGeAlD
Ponatinib—SRC—female gonad—uterine fibroid	0.00297	0.0057	CbGeAlD
Ponatinib—KIT—uterus—uterine fibroid	0.00296	0.00568	CbGeAlD
Ponatinib—ABL1—decidua—uterine fibroid	0.00294	0.00565	CbGeAlD
Ponatinib—ABL1—urethra—uterine fibroid	0.00284	0.00545	CbGeAlD
Ponatinib—ABL1—endometrium—uterine fibroid	0.00279	0.00537	CbGeAlD
Ponatinib—KDR—female gonad—uterine fibroid	0.00273	0.00525	CbGeAlD
Ponatinib—KDR—vagina—uterine fibroid	0.00271	0.00521	CbGeAlD
Ponatinib—ABL1—mammalian vulva—uterine fibroid	0.0027	0.00519	CbGeAlD
Ponatinib—KIT—female reproductive system—uterine fibroid	0.00266	0.00511	CbGeAlD
Ponatinib—ABL1—cardiac atrium—uterine fibroid	0.00259	0.00497	CbGeAlD
Ponatinib—ABL1—uterus—uterine fibroid	0.00257	0.00495	CbGeAlD
Ponatinib—ABCG2—myometrium—uterine fibroid	0.0025	0.00481	CbGeAlD
Ponatinib—KIT—female gonad—uterine fibroid	0.00242	0.00465	CbGeAlD
Ponatinib—KIT—vagina—uterine fibroid	0.0024	0.00462	CbGeAlD
Ponatinib—ABL1—female reproductive system—uterine fibroid	0.00231	0.00445	CbGeAlD
Ponatinib—ABL1—female gonad—uterine fibroid	0.0021	0.00405	CbGeAlD
Ponatinib—ABL1—vagina—uterine fibroid	0.00209	0.00402	CbGeAlD
Ponatinib—FGFR2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00201	0.00418	CbGpPWpGaD
Ponatinib—KIT—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.002	0.00417	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by ERBB4—PGR—uterine fibroid	0.00199	0.00414	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00198	0.00414	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00198	0.00413	CbGpPWpGaD
Ponatinib—KIT—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00197	0.0041	CbGpPWpGaD
Ponatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00197	0.0041	CbGpPWpGaD
Ponatinib—KIT—Signaling by ERBB4—PGR—uterine fibroid	0.00195	0.00406	CbGpPWpGaD
Ponatinib—ABCG2—uterine cervix—uterine fibroid	0.00195	0.00374	CbGeAlD
Ponatinib—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00194	0.00405	CbGpPWpGaD
Ponatinib—FGFR2—Downstream signal transduction—TNRC6B—uterine fibroid	0.00192	0.00399	CbGpPWpGaD
Ponatinib—LCK—PI-3K cascade—TNRC6B—uterine fibroid	0.00191	0.00399	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by FGFR—TNRC6B—uterine fibroid	0.00191	0.00397	CbGpPWpGaD
Ponatinib—FGFR1—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.0019	0.00396	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.0019	0.00395	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00189	0.00395	CbGpPWpGaD
Ponatinib—FGFR2—DAP12 signaling—TNRC6B—uterine fibroid	0.00189	0.00393	CbGpPWpGaD
Ponatinib—KIT—Downstream signal transduction—TNRC6B—uterine fibroid	0.00188	0.00392	CbGpPWpGaD
Ponatinib—KIT—Signaling by FGFR—TNRC6B—uterine fibroid	0.00187	0.0039	CbGpPWpGaD
Ponatinib—LCK—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00187	0.0039	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00187	0.0039	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00186	0.00389	CbGpPWpGaD
Ponatinib—KIT—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00186	0.00388	CbGpPWpGaD
Ponatinib—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00186	0.00388	CbGpPWpGaD
Ponatinib—ABCG2—decidua—uterine fibroid	0.00185	0.00357	CbGeAlD
Ponatinib—LCK—GAB1 signalosome—TNRC6B—uterine fibroid	0.00185	0.00386	CbGpPWpGaD
Ponatinib—KIT—DAP12 signaling—TNRC6B—uterine fibroid	0.00185	0.00386	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by ERBB4—PGR—uterine fibroid	0.00185	0.00386	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by ERBB4—PGR—uterine fibroid	0.00185	0.00385	CbGpPWpGaD
Ponatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00183	0.00381	CbGpPWpGaD
Ponatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00181	0.00378	CbGpPWpGaD
Ponatinib—CYP2C8—endometrium—uterine fibroid	0.00181	0.00348	CbGeAlD
Ponatinib—CYP3A5—uterine cervix—uterine fibroid	0.00181	0.00347	CbGeAlD
Ponatinib—SRC—Plasma membrane estrogen receptor signaling—ESR1—uterine fibroid	0.0018	0.00375	CbGpPWpGaD
Ponatinib—ABCG2—urethra—uterine fibroid	0.00179	0.00344	CbGeAlD
Ponatinib—FGFR1—Downstream signal transduction—TNRC6B—uterine fibroid	0.00179	0.00372	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signal transduction—TNRC6B—uterine fibroid	0.00178	0.00371	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by FGFR—TNRC6B—uterine fibroid	0.00178	0.0037	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00178	0.0037	CbGpPWpGaD
Ponatinib—FGFR2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00178	0.0037	CbGpPWpGaD
Ponatinib—FGFR2—DAP12 interactions—TNRC6B—uterine fibroid	0.00178	0.0037	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by FGFR—TNRC6B—uterine fibroid	0.00177	0.00369	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00177	0.00368	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00176	0.00367	CbGpPWpGaD
Ponatinib—ABCG2—endometrium—uterine fibroid	0.00176	0.00339	CbGeAlD
Ponatinib—FGFR2—Signaling by EGFR—TNRC6B—uterine fibroid	0.00176	0.00367	CbGpPWpGaD
Ponatinib—FGFR1—DAP12 signaling—TNRC6B—uterine fibroid	0.00176	0.00367	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by NGF—TNRC6B—uterine fibroid	0.00176	0.00366	CbGpPWpGaD
Ponatinib—PDGFRA—DAP12 signaling—TNRC6B—uterine fibroid	0.00175	0.00366	CbGpPWpGaD
Ponatinib—LYN—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00175	0.00364	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00174	0.00363	CbGpPWpGaD
Ponatinib—KIT—DAP12 interactions—TNRC6B—uterine fibroid	0.00174	0.00363	CbGpPWpGaD
Ponatinib—KIT—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00174	0.00363	CbGpPWpGaD
Ponatinib—KIT—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00174	0.00363	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by PDGF—TNRC6B—uterine fibroid	0.00174	0.00362	CbGpPWpGaD
Ponatinib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00173	0.00361	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00173	0.0036	CbGpPWpGaD
Ponatinib—KIT—Signaling by EGFR—TNRC6B—uterine fibroid	0.00173	0.0036	CbGpPWpGaD
Ponatinib—KIT—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00171	0.00357	CbGpPWpGaD
Ponatinib—KIT—Signaling by PDGF—TNRC6B—uterine fibroid	0.00171	0.00355	CbGpPWpGaD
Ponatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0017	0.00355	CbGpPWpGaD
Ponatinib—ABCG2—mammalian vulva—uterine fibroid	0.0017	0.00327	CbGeAlD
Ponatinib—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00168	0.00351	CbGpPWpGaD
Ponatinib—FGFR1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00165	0.00345	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00165	0.00345	CbGpPWpGaD
Ponatinib—FGFR1—DAP12 interactions—TNRC6B—uterine fibroid	0.00165	0.00345	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00165	0.00344	CbGpPWpGaD
Ponatinib—PDGFRA—DAP12 interactions—TNRC6B—uterine fibroid	0.00165	0.00344	CbGpPWpGaD
Ponatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00165	0.00344	CbGpPWpGaD
Ponatinib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.00165	0.00343	CbGpPWpGaD
Ponatinib—FGFR2—B Cell Activation—TNRC6B—uterine fibroid	0.00164	0.00342	CbGpPWpGaD
Ponatinib—SRC—GAB1 signalosome—TNRC6B—uterine fibroid	0.00164	0.00342	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00164	0.00342	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00164	0.00342	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by EGFR—TNRC6B—uterine fibroid	0.00164	0.00341	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00163	0.00339	CbGpPWpGaD
Ponatinib—ABCG2—uterus—uterine fibroid	0.00162	0.00312	CbGeAlD
Ponatinib—PDGFRA—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00162	0.00338	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by PDGF—TNRC6B—uterine fibroid	0.00162	0.00337	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by PDGF—TNRC6B—uterine fibroid	0.00161	0.00336	CbGpPWpGaD
Ponatinib—KIT—B Cell Activation—TNRC6B—uterine fibroid	0.00161	0.00336	CbGpPWpGaD
Ponatinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0016	0.00332	CbGpPWpGaD
Ponatinib—FGFR2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00157	0.00328	CbGpPWpGaD
Ponatinib—KIT—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00154	0.00322	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by ERBB4—ESR1—uterine fibroid	0.00154	0.00321	CbGpPWpGaD
Ponatinib—FGFR1—B Cell Activation—TNRC6B—uterine fibroid	0.00153	0.00319	CbGpPWpGaD
Ponatinib—PDGFRA—B Cell Activation—TNRC6B—uterine fibroid	0.00153	0.00318	CbGpPWpGaD
Ponatinib—FGFR3—Disease—HPSE2—uterine fibroid	0.0015	0.00314	CbGpPWpGaD
Ponatinib—CYP2C8—female reproductive system—uterine fibroid	0.0015	0.00288	CbGeAlD
Ponatinib—FGFR1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00147	0.00305	CbGpPWpGaD
Ponatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00146	0.00305	CbGpPWpGaD
Ponatinib—LYN—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00146	0.00303	CbGpPWpGaD
Ponatinib—LCK—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00143	0.00298	CbGpPWpGaD
Ponatinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0014	0.00292	CbGpPWpGaD
Ponatinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00138	0.00288	CbGpPWpGaD
Ponatinib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00138	0.00288	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00137	0.00285	CbGpPWpGaD
Ponatinib—CYP2C8—vagina—uterine fibroid	0.00136	0.00261	CbGeAlD
Ponatinib—FGFR4—Innate Immune System—TNRC6B—uterine fibroid	0.00136	0.00283	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00135	0.00281	CbGpPWpGaD
Ponatinib—LYN—B Cell Activation—TNRC6B—uterine fibroid	0.00135	0.00281	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB4—PGR—uterine fibroid	0.00133	0.00278	CbGpPWpGaD
Ponatinib—ABCG2—female gonad—uterine fibroid	0.00133	0.00255	CbGeAlD
Ponatinib—ABCG2—vagina—uterine fibroid	0.00132	0.00254	CbGeAlD
Ponatinib—FGFR4—Adaptive Immune System—TNRC6B—uterine fibroid	0.0013	0.00271	CbGpPWpGaD
Ponatinib—LCK—Downstream signal transduction—TNRC6B—uterine fibroid	0.00129	0.00268	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR—TNRC6B—uterine fibroid	0.00128	0.00267	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00127	0.00266	CbGpPWpGaD
Ponatinib—LCK—DAP12 signaling—TNRC6B—uterine fibroid	0.00127	0.00264	CbGpPWpGaD
Ponatinib—SRC—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00127	0.00264	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00125	0.00261	CbGpPWpGaD
Ponatinib—ABCB1—myometrium—uterine fibroid	0.00123	0.00237	CbGeAlD
Ponatinib—CYP3A5—female gonad—uterine fibroid	0.00123	0.00237	CbGeAlD
Ponatinib—CYP3A5—vagina—uterine fibroid	0.00122	0.00235	CbGeAlD
Ponatinib—FGFR2—Signaling by NGF—TNRC6B—uterine fibroid	0.00121	0.00252	CbGpPWpGaD
Ponatinib—LCK—DAP12 interactions—TNRC6B—uterine fibroid	0.00119	0.00249	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00119	0.00249	CbGpPWpGaD
Ponatinib—LCK—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00119	0.00249	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—TNRC6B—uterine fibroid	0.00119	0.00248	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—TNRC6B—uterine fibroid	0.00118	0.00246	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—MED12—uterine fibroid	0.00118	0.00246	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00117	0.00244	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—TNRC6B—uterine fibroid	0.00117	0.00243	CbGpPWpGaD
Ponatinib—SRC—Downstream signal transduction—TNRC6B—uterine fibroid	0.00114	0.00237	CbGpPWpGaD
Ponatinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00113	0.00236	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR—TNRC6B—uterine fibroid	0.00113	0.00236	CbGpPWpGaD
Ponatinib—SRC—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00113	0.00235	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—TNRC6B—uterine fibroid	0.00113	0.00235	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—TNRC6B—uterine fibroid	0.00112	0.00234	CbGpPWpGaD
Ponatinib—SRC—Leptin signaling pathway—ESR1—uterine fibroid	0.00111	0.00231	CbGpPWpGaD
Ponatinib—LCK—B Cell Activation—TNRC6B—uterine fibroid	0.0011	0.0023	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by ERBB4—ESR1—uterine fibroid	0.00106	0.00221	CbGpPWpGaD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00106	0.0022	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00106	0.0022	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—TNRC6B—uterine fibroid	0.00105	0.00218	CbGpPWpGaD
Ponatinib—KIT—Signaling by ERBB4—ESR1—uterine fibroid	0.00104	0.00217	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00104	0.00216	CbGpPWpGaD
Ponatinib—FGFR2—Disease—HPSE2—uterine fibroid	0.00103	0.00216	CbGpPWpGaD
Ponatinib—BCR—Disease—TNRC6B—uterine fibroid	0.00103	0.00216	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—TNRC6B—uterine fibroid	0.00103	0.00215	CbGpPWpGaD
Ponatinib—KIT—Disease—HPSE2—uterine fibroid	0.00102	0.00212	CbGpPWpGaD
Ponatinib—CYP3A4—female reproductive system—uterine fibroid	0.00102	0.00195	CbGeAlD
Ponatinib—FGFR3—Innate Immune System—TNRC6B—uterine fibroid	0.001	0.00209	CbGpPWpGaD
Ponatinib—CYP2D6—female reproductive system—uterine fibroid	0.001	0.00192	CbGeAlD
Ponatinib—FGFR1—Signaling by ERBB4—ESR1—uterine fibroid	0.000988	0.00206	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by ERBB4—ESR1—uterine fibroid	0.000985	0.00205	CbGpPWpGaD
Ponatinib—FGFR1—Disease—HPSE2—uterine fibroid	0.000965	0.00201	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—TNRC6B—uterine fibroid	0.000963	0.00201	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—HPSE2—uterine fibroid	0.000962	0.002	CbGpPWpGaD
Ponatinib—ABCB1—uterine cervix—uterine fibroid	0.00096	0.00185	CbGeAlD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000936	0.00195	CbGpPWpGaD
Ponatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000915	0.00191	CbGpPWpGaD
Ponatinib—ABCB1—decidua—uterine fibroid	0.000915	0.00176	CbGeAlD
Ponatinib—CYP2D6—female gonad—uterine fibroid	0.00091	0.00175	CbGeAlD
Ponatinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000903	0.00188	CbGpPWpGaD
Ponatinib—ABCB1—urethra—uterine fibroid	0.000882	0.0017	CbGeAlD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00087	0.00181	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MED12—uterine fibroid	0.00087	0.00181	CbGpPWpGaD
Ponatinib—ABCB1—endometrium—uterine fibroid	0.000868	0.00167	CbGeAlD
Ponatinib—ABCB11—Metabolism—HPSE2—uterine fibroid	0.000854	0.00178	CbGpPWpGaD
Ponatinib—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000847	0.00177	CbGpPWpGaD
Ponatinib—ABCB1—mammalian vulva—uterine fibroid	0.00084	0.00161	CbGeAlD
Ponatinib—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000836	0.00174	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000823	0.00172	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000821	0.00171	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000821	0.00171	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—TNRC6B—uterine fibroid	0.000813	0.00169	CbGpPWpGaD
Ponatinib—ABCB1—uterus—uterine fibroid	0.0008	0.00154	CbGeAlD
Ponatinib—FGFR4—Immune System—TNRC6B—uterine fibroid	0.00079	0.00165	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MED12—uterine fibroid	0.000765	0.00159	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000762	0.00159	CbGpPWpGaD
Ponatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000742	0.00155	CbGpPWpGaD
Ponatinib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000734	0.00153	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TNRC6B—uterine fibroid	0.000729	0.00152	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TNRC6B—uterine fibroid	0.000725	0.00151	CbGpPWpGaD
Ponatinib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000724	0.00151	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000721	0.0015	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—TNRC6B—uterine fibroid	0.00072	0.0015	CbGpPWpGaD
Ponatinib—ABCB1—female reproductive system—uterine fibroid	0.000719	0.00138	CbGeAlD
Ponatinib—BCR—Signaling Pathways—PGR—uterine fibroid	0.000717	0.00149	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB4—ESR1—uterine fibroid	0.000712	0.00148	CbGpPWpGaD
Ponatinib—LCK—Disease—HPSE2—uterine fibroid	0.000696	0.00145	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—TNRC6B—uterine fibroid	0.00069	0.00144	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000687	0.00143	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—TNRC6B—uterine fibroid	0.000677	0.00141	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—TNRC6B—uterine fibroid	0.000662	0.00138	CbGpPWpGaD
Ponatinib—ABCB1—female gonad—uterine fibroid	0.000654	0.00126	CbGeAlD
Ponatinib—KIT—Adaptive Immune System—TNRC6B—uterine fibroid	0.000651	0.00136	CbGpPWpGaD
Ponatinib—ABCB1—vagina—uterine fibroid	0.00065	0.00125	CbGeAlD
Ponatinib—FGFR1—Innate Immune System—TNRC6B—uterine fibroid	0.000643	0.00134	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—TNRC6B—uterine fibroid	0.000641	0.00134	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000617	0.00129	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—TNRC6B—uterine fibroid	0.000616	0.00128	CbGpPWpGaD
Ponatinib—SRC—Disease—HPSE2—uterine fibroid	0.000616	0.00128	CbGpPWpGaD
Ponatinib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.000603	0.00126	CbGpPWpGaD
Ponatinib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000594	0.00124	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—TNRC6B—uterine fibroid	0.000584	0.00122	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—TNRC6B—uterine fibroid	0.000566	0.00118	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000564	0.00118	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000563	0.00117	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MED12—uterine fibroid	0.000555	0.00116	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—TNRC6B—uterine fibroid	0.000543	0.00113	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TNRC6B—uterine fibroid	0.000539	0.00112	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000525	0.00109	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TNRC6B—uterine fibroid	0.000511	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—PGR—uterine fibroid	0.000505	0.00105	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—TNRC6B—uterine fibroid	0.000464	0.000966	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000445	0.000928	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—TNRC6B—uterine fibroid	0.00041	0.000855	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000404	0.000843	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TNRC6B—uterine fibroid	0.000402	0.000837	CbGpPWpGaD
Ponatinib—KIT—Immune System—TNRC6B—uterine fibroid	0.000395	0.000822	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—TNRC6B—uterine fibroid	0.000394	0.000821	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000394	0.000821	CbGpPWpGaD
Ponatinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000389	0.00081	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—ESR1—uterine fibroid	0.000383	0.000798	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TNRC6B—uterine fibroid	0.000378	0.000787	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TNRC6B—uterine fibroid	0.000374	0.00078	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—PGR—uterine fibroid	0.000374	0.000779	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TNRC6B—uterine fibroid	0.000374	0.000778	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TNRC6B—uterine fibroid	0.000371	0.000773	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—MED12—uterine fibroid	0.000366	0.000762	CbGpPWpGaD
Ponatinib—KIT—Disease—TNRC6B—uterine fibroid	0.000364	0.000759	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.00035	0.00073	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TNRC6B—uterine fibroid	0.000346	0.000721	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TNRC6B—uterine fibroid	0.000345	0.000719	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000337	0.000702	CbGpPWpGaD
Ponatinib—LYN—Immune System—TNRC6B—uterine fibroid	0.000329	0.000687	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TNRC6B—uterine fibroid	0.000329	0.000686	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000328	0.000683	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PGR—uterine fibroid	0.000326	0.000679	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000311	0.000648	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CYP17A1—uterine fibroid	0.000306	0.000638	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000305	0.000636	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.000288	0.000599	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000282	0.000587	CbGpPWpGaD
Ponatinib—LCK—Immune System—TNRC6B—uterine fibroid	0.00027	0.000563	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—ESR1—uterine fibroid	0.00027	0.000562	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TNRC6B—uterine fibroid	0.00026	0.000541	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PGR—uterine fibroid	0.000257	0.000536	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TNRC6B—uterine fibroid	0.000255	0.000532	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PGR—uterine fibroid	0.000253	0.000526	CbGpPWpGaD
Ponatinib—LCK—Disease—TNRC6B—uterine fibroid	0.000249	0.00052	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TNRC6B—uterine fibroid	0.000242	0.000505	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—MED12—uterine fibroid	0.000242	0.000504	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TNRC6B—uterine fibroid	0.000241	0.000503	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PGR—uterine fibroid	0.00024	0.000499	CbGpPWpGaD
Ponatinib—SRC—Immune System—TNRC6B—uterine fibroid	0.000239	0.000498	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PGR—uterine fibroid	0.000239	0.000498	CbGpPWpGaD
Ponatinib—SRC—Disease—TNRC6B—uterine fibroid	0.000221	0.00046	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TNRC6B—uterine fibroid	0.000213	0.000444	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PGR—uterine fibroid	0.000211	0.000439	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000202	0.000422	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—ESR1—uterine fibroid	0.0002	0.000416	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000188	0.000392	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TNRC6B—uterine fibroid	0.000175	0.000364	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—ESR1—uterine fibroid	0.000174	0.000362	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MED12—uterine fibroid	0.000173	0.000361	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PGR—uterine fibroid	0.000173	0.00036	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TNRC6B—uterine fibroid	0.000155	0.000322	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PGR—uterine fibroid	0.000153	0.000319	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MED12—uterine fibroid	0.00015	0.000313	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CYP17A1—uterine fibroid	0.000145	0.000302	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—ESR1—uterine fibroid	0.000137	0.000286	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—ESR1—uterine fibroid	0.000135	0.000281	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MED12—uterine fibroid	0.000131	0.000272	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—ESR1—uterine fibroid	0.000128	0.000267	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—ESR1—uterine fibroid	0.000128	0.000266	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	0.000126	0.000262	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MED12—uterine fibroid	0.000123	0.000257	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ESR1—uterine fibroid	0.000113	0.000235	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000109	0.000228	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	0.000103	0.000215	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ESR1—uterine fibroid	9.23e-05	0.000192	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ESR1—uterine fibroid	8.17e-05	0.00017	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MED12—uterine fibroid	8.05e-05	0.000168	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	6.74e-05	0.00014	CbGpPWpGaD
